Bloodstream infections in critically ill patients: an expert statement

JF Timsit, E Ruppé, F Barbier, A Tabah… - Intensive care medicine, 2020 - Springer
Bloodstream infection (BSI) is defined by positive blood cultures in a patient with systemic
signs of infection and may be either secondary to a documented source or primary—that is …

[HTML][HTML] Recommendation of antimicrobial dosing optimization during continuous renal replacement therapy

L Li, X Li, Y Xia, Y Chu, H Zhong, J Li, P Liang… - Frontiers in …, 2020 - frontiersin.org
Continuous Renal Replacement Therapy (CRRT) is more and more widely used in patients
for various indications recent years. It is still intricate for clinicians to decide a suitable …

Contemporary Management of Severe Acute Kidney Injury and Refractory Cardiorenal Syndrome: JACC Council Perspectives

JC Jentzer, A Bihorac, SB Brusca… - Journal of the American …, 2020 - jacc.org
Acute kidney injury (AKI) and cardiorenal syndrome (CRS) are increasingly prevalent in
hospitalized patients with cardiovascular disease and remain associated with poor short …

Pharmacokinetic/pharmacodynamic target attainment in critically ill renal patients on antimicrobial usage: focus on novel beta-lactams and beta lactams/beta …

M Gatti, F Pea - Expert Review of Clinical Pharmacology, 2021 - Taylor & Francis
Introduction Several novel beta-lactams (BLs) and/or beta lactams/beta-lactamase inhibitors
(BL/BLIs) have been recently developed for the management of multidrug-resistant bacterial …

Antimicrobial dose reduction in continuous renal replacement therapy: myth or real need? A practical approach for guiding dose optimization of novel antibiotics

M Gatti, F Pea - Clinical Pharmacokinetics, 2021 - Springer
Acute kidney injury represents a common complication in critically ill patients affected by
septic shock and in many cases continuous renal replacement therapy (CRRT) may be …

Population pharmacokinetics of polymyxin B in critically ill patients receiving continuous venovenous haemofiltration

P Wang, H Xing, F Zhang, S Liu, Y Lu, X Zhang… - International Journal of …, 2022 - Elsevier
Antibiotic dosing in critically ill patients undergoing continuous renal replacement therapy is
considered challenging. This study aimed to analyse the population pharmacokinetics of …

Antiviral agent therapy optimization in special populations of COVID-19 patients

L Li, X Wang, R Wang, Y Hu, S Jiang… - … design, development and …, 2020 - Taylor & Francis
Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) is now a global outbreak of disease. The antiviral …

A UPLC-MS/MS method for simultaneous determination of eight special-grade antimicrobials in human plasma and application in TDM

Y Qi, G Liu - Journal of Pharmaceutical and Biomedical Analysis, 2022 - Elsevier
Abstract Linezolid, vancomycin, teicoplanin, tigecycline, imipenem, meropenem,
voriconazole, and micafungin are eight special-grade antimicrobials commonly used for …

Therapeutic drug monitoring of antibiotic drugs in patients receiving continuous renal replacement therapy or intermittent hemodialysis: A critical review

E Matusik, C Boidin, A Friggeri… - Therapeutic Drug …, 2022 - ingentaconnect.com
Purpose: Antibiotics are frequently used in patients receiving intermittent or continuous renal
replacement therapy (RRT). Continuous renal replacement may alter the pharmacokinetics …

Piperacillin-tazobactam in intensive care units: a review of population pharmacokinetic analyses

I El-Haffaf, JA Caissy, A Marsot - Clinical pharmacokinetics, 2021 - Springer
Piperacillin-tazobactam is a potent β-lactam/β-lactamase inhibitor antibiotic commonly
prescribed in the intensive care unit setting. Admitted patients often show large variability in …